09:00

THE GENETICS IN THE AORTOPATHY CLINIC – AN UPDATE

Moderators: Julie De Backer, John Elefteriades, Bart Loeys, Ingrid van de Laar

• 09:00 Can genes help in risk prediction? Dianna Milewicz | See presentation
• 09:07 Can gene variants help in risk prediction? Guillaume Jondeau | See presentation
• 09:14 Can genetic modifiers help in risk prediction ? Bart Loeys | See presentation
• 09:21 Variant curation: tips and tricks. Laura Muiño Mosquera | See presentation
• 09:52 Interpretation and clinical implications of population based testing: the genomic first approach. Julie De Backer | See presentation
• 09:59 Zebrafish modeling of Variants of Uncertain Significance: Preliminary Results. Bulat A. Ziganshin, Andrew Prendergast | See presentation

14:00

MEDICAL TREATMENT IN MARFAN SYNDROME AND RELATED HTAD – AN UPDATE

Moderators: Julie De Backer, Guillaume Jondeau

• 14:00 Threats and opportunities with the use of animal models for Marfan syndrome – lessons learned and preliminary results. Julie De Backer | See presentation
• 14:07 Beta-blockers and ARBs: friends or competitors? Guillaume Jondeau | See presentation
• 14:14 The NO pathway in Marfan disease: the way to go? Patrick Sips | See presentation
• 14:21 Tailored drug treatment: myth or reality. Dianna Milewicz | See presentation

14:50

MEDICAL TREATMENT OF AAA

Moderators: Ronald Dalman, Jonathan Golledge

• 14:57 Stem cell therapies for aorta. Tulga Ulus | See presentation
• 15:04 Unrealised potential of intensive low density lipoprotein- cholesterol reduction in patients with small AAA. Jonathan Golledge | See presentation